Effect of Competition Bias in Safety Signal Generation-Reference-Cited by-同舟云学术

Effect of Competition Bias in Safety Signal Generation

Published:2012-10 Issue:10 Volume:35 Page:855-864
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Pariente Antoine, ,Avillach Paul,Salvo Francesco,Thiessard Frantz,Miremont-Salamé Ghada,Fourrier-Reglat Annie,Haramburu Françoise,Bégaud Bernard,Moore Nicholas

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/BF03261981.pdf

Reference48 articles.

1. Begaud B, Chaslerie A, Haramburu F. Organization and results of drug vigilance in France. Rev Epidemiol Sante Publique 1994; 42(5): 416–23

2. Rawlins MD. Spontaneous reporting of adverse drug reactions. II: Uses. Br J Clin Pharmacol 1988 Jul; 26(1): 7–11

3. Rawlins MD. Spontaneous reporting of adverse drug reactions. I: the data. Br J Clin Pharmacol 1988 Jul; 26(1): 1–5

4. van Puijenbroek EP, Bate A, Leufkens HG, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002 Jan–Feb; 11(1): 3–10

5. Pariente A, Daveluy A, Laribiere-Benard A, et al. Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA. Drug Saf 2009; 32(5): 441–7

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of Antineoplastic Agents Inducing Taste and Smell Disorders Using the FAERS Database;Pharmaceuticals;2024-08-23

2. Nuclear Receptors and Stress Response Pathways Associated with the Development of Oral Mucositis Induced by Antineoplastic Agents;Pharmaceuticals;2024-08-20

3. Fact-Finding Survey and Exploration of Preventive Drugs for Antineoplastic Drug-Induced Oral Mucositis Using the Japanese Adverse Drug Event Report Database;Scientia Pharmaceutica;2024-06-20

4. Impact of the vaccination against SARS-CoV-2 campaign on disproportionality indicator from the WHO pharmacovigilance database: A competition bias study from case/non-case analysis;Therapies;2024-03

5. Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System;BioDrugs;2024-02-25